Your browser doesn't support javascript.
loading
Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series.
Koumaki, D; Krueger-Krasagakis, S-E; Papadakis, M; Katoulis, A; Koumaki, V; Evangelou, G; Stefanidou, M; Mylonakis, D; Zografaki, K; Krasagakis, K.
Afiliação
  • Koumaki D; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
  • Krueger-Krasagakis SE; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
  • Papadakis M; Department of Surgery II, Witten/Herdecke University, Witten, Germany.
  • Katoulis A; 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, "Attikon" General University Hospital, Athens, Greece.
  • Koumaki V; Microbiology Department, Medical School of Athens, Athens, Greece.
  • Evangelou G; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
  • Stefanidou M; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
  • Mylonakis D; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
  • Zografaki K; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
  • Krasagakis K; Dermatology Department, University Hospital of Heraklion, Crete, Greece.
J Eur Acad Dermatol Venereol ; 36(2): e85-e86, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34606142

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Herpes Zoster Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Herpes Zoster Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article